Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission
Clinical trial NCT01246440 · COMPLETED
Trial details
- NCT number
- NCT01246440
- Sponsor
- Grupo Español de Investigación en Cáncer de Ovario
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.